or Try an Advanced Search...

    ETF Components for FLHK - Franklin FTSE Hong Kong ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    BGNE D 2.02 1.40

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Bruton's Tyrosine Kinase Cancer IBD 50 Lymphoma Monoclonal Antibodies Monoclonal Antibody Oncogenes Protein Kinase Ras Subfamily Rp1
    Industries: Biotechnology

    Recent News for Franklin FTSE Hong Kong ETF & its Holdings

    Date Stock Title
    Nov 6 BGNE BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion
    Nov 6 BGNE BeiGene to Present at the Jefferies London Healthcare Conference
    Nov 5 BGNE BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
    The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of FTSE Hong Kong RIC Capped Index (the FTSE Hong Kong Capped Index). Under normal market conditions, the fund invests at least 80% of its assets in the component securities of the FTSE Hong Kong Capped Index and in depositary receipts representing such securities. The FTSE Hong Kong Capped Index is based on the FTSE Hong Kong Index and is designed to measure the performance of Hong Kong large- and mid-capitalization stocks. The fund is non-diversified.
    Exchange Traded Fund ETF Stock Market Index Ftse 100 Index Ftse Group
    Back to the Main FLHK Page...